Read More Pharma Industry News Stokes’ STK-001 secures FDA orphan drug designation for Dravet Syndrome US biotech company Stoke Therapeutics has secured orphan drug designation for its lead product candidate – STK-001 from… bypharmanewsdailyAugust 7, 2019
